Clinical Trials Directory

Trials / Completed

CompletedNCT00737997

Effect of Early Morphine Administration on the Development of Acute Opioid Tolerance During Pediatric Scoliosis Surgery

Effect of Early Administration of Morphine on the Development of Acute Opioid Tolerance During Infusion of Remifentanil for Pediatric Scoliosis Surgery

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
40 (actual)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
All
Age
11 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine if morphine administered by bolus before initiating Remifentanil by infusion decreases the incidence of acute post-operative opioid tolerance as demonstrated by decreased post - operative morphine consumption in children undergoing scoliosis surgery.

Detailed description

At our institution, a study has recently demonstrated that intraoperative infusion of remifentanil is associated with development of clinically relevant acute opioid tolerance in adolescents undergoing scoliosis surgery. This results in increased morphine consumption which in turn is associated with increased incidence of side effects such as respiratory depression, nausea and vomiting, pruritus, ileus and urinary retention. All of these side effects can result in increased consumption of rescue medications with the additional potential for increased duration of patient stay. Any measures that can be introduced to decrease the development of acute opioid tolerance in this patient population would have significant impact on patient morbidity, patient comfort and possibly duration of patient stay.

Conditions

Interventions

TypeNameDescription
DRUGMorphine150 mcg/kg diluted in normal saline to a volume of 10 ml at time of induction of anesthesia
OTHERSaline10 ml saline alone

Timeline

Start date
2006-12-01
Primary completion
2007-12-01
Completion
2008-02-01
First posted
2008-08-20
Last updated
2014-11-19

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00737997. Inclusion in this directory is not an endorsement.